Skip to main content
. 2019 Feb 20;43(5):640–648. doi: 10.4093/dmj.2018.0137

Fig. 1. Flow chart of the study design. MET, metformin; SU, sulfonylurea; DPP4i, dipeptidyl peptidase-4 inhibitor; TZD, thiazolidinedione.

Fig. 1